Safety and efficacy of inhaled nebulised interferon beta-1a (SNG001) for treatment of SARS-CoV-2 infection: a randomised, double-blind, placebo-controlled, phase 2 trial
| author |
|
| created | [InstanceEdit:9734386] Stephan, Ralf, 2021-06-17 |
| dbId | 9734400 |
| displayName | Safety and efficacy of inhaled nebulised interferon beta-1a (SNG001) for treatment of SARS-CoV-2 infection: a randomised, double-blind, placebo-controlled, phase 2 trial |
| journal | Lancet Respir Med |
| modified | [InstanceEdit:9773827] Stephan, Ralf, 2022-05-10 |
| pages | 196-206 |
| pubMedIdentifier | 33189161 |
| schemaClass | LiteratureReference |
| title | Safety and efficacy of inhaled nebulised interferon beta-1a (SNG001) for treatment of SARS-CoV-2 infection: a randomised, double-blind, placebo-controlled, phase 2 trial |
| url | http://www.ncbi.nlm.nih.gov/pubmed/33189161 |
| volume | 9 |
| year | 2021 |
Referrals
© 2026 Reactome
